Green tea extract and the risk of drug-induced liver injury

Bibliography

• Martin LC. Tea. The drink that changed the world. Tuttle Publishing; North Clarendon, Vermont, USA: 2007
   Google Scholar
• National Institutes of Health (NIH) and LiverTox: drug record. Green tea (Camellia sinensis). Last updated 2 July 2014. Available from: http://livertox.nlm.nih.gov/GreenTea.htm [Last accessed 30 July 2014]
   Google Scholar
• Cabrera C, Artacho R, Giménez R. Beneficial effects of green tea: a review. J Am Coll Nutr 2006;25:79-99
   PubMed Web of Science ®Google Scholar
• Chacko SM, Thambi PT, Kuttan R, et al. Beneficial effects of green tea: a literature review. Chin Med 2010.5:13. Available from: www.cmjournal.org/content/5/1/13 [Last accessed 30 July 2014]
   Google Scholar
• Bun SS, Bun H, Guédon D, et al. Effect of green tea extracts on liver functions in Wistar rats. Food Chem Toxicol 2006;44:1108-13
   PubMed Web of Science ®Google Scholar
• Teschke R, Bahre R. Severe hepatotoxicity by Indian Ayurvedic herbal products: a structured causality assessment. Ann Hepatol 2009;8:258-66
   PubMed Web of Science ®Google Scholar
• Teschke R, Schwarzenboeck A, Hennermann KH. Kava hepatotoxicity: a clinical survey and critical analysis of 26 suspected cases. Eur J Gastroenterol Hepatol 2008;20:1182-93
   PubMed Web of Science ®Google Scholar
• Teschke R, Glass X, Schulze J, et al. Suspected Greater Celandine hepatotoxicity: liver specific causality evaluation of published case reports from Europe. Eur J Gastroenterol Hepatol 2012;24:270-80
   PubMed Web of Science ®Google Scholar
• Teschke R. Kava hepatotoxicity – a clinical review. Ann Hepatol 2010;9:251-65
   PubMed Web of Science ®Google Scholar
• de Abajo FJ, Montero D, Madurga M, et al. Acute and clinically relevant drug-induced liver injury: population based case –control study. Br J Clin Pharmacol 2004;58:71-80
   PubMed Web of Science ®Google Scholar
• Gavilan JC, Bermudez FJ, Salgado F, et al. Phytotherapy and hepatitis. Rev Clin Esp 1999;199:693-4
   PubMed Web of Science ®Google Scholar
• Seddik M, Lucidarme D, Creusy C, et al. Is Exolise hepatotoxic? Gastroenterol Clin Biol 2001;25:834-5
   PubMed Web of Science ®Google Scholar
• Thiolet C, Mennecier D, Bredin C, et al. Acute cytolysis induced by Chinese tea. Gastroenterol Clin Biol 2002;26:939-40
   PubMed Web of Science ®Google Scholar
• Bajaj J, Knox JF, Komorowski R, et al. The irony of herbal hepatotoxicity: ma-Huang-induced hepatotoxicity associated with compound heterozygosity for hereditary hemochromatosis. Dig Dis Sci 2003;48:1925-8
   PubMed Web of Science ®Google Scholar
• Kanda T, Yokosuka O, Tada M, et al. N-nitroso-fenfluramine hepatotoxicity resembling chronic hepatitis. J Gastroenterol Hepatol 2003;18:999-1000
   PubMed Web of Science ®Google Scholar
• Kanda T, Yokosuka O, Okada O, et al. Severe hepatotoxicity associated with Chinese diet product “Ohnshidou-Genbi-Kounou”. J Gastroenterol Hepatol 2003;18:354-5
   PubMed Web of Science ®Google Scholar
• Pedros C, Cereza G, Garcia N, et al. Liver toxicity of Camellia sinensis dried ethanolic extract. Med Clin (Barc) 2003;121:598-9
   PubMed Web of Science ®Google Scholar
• Vial T, Bernard G, Lewden B, et al. Acute hepatitis due to Exolise, a Camellia sinensis-derived drug. Gastroenterol Clin Biol 2003;27:1166-7
   PubMed Web of Science ®Google Scholar
• Duenas Sadornil C, Fabregas Puigitio S, Durandez R. Hepatotoxicity due to Camelia sinensis. Med Clin (Barc) 2004;122:677-8
   PubMed Web of Science ®Google Scholar
• Garcia-Moran S, Saez-Royuela F, Gento E, et al. Acute hepatitis associated with Camellia tea and Orthosiphon stamineus ingestion. Gastroenterol Hepatol 2004;27:559-60
   PubMedGoogle Scholar
• Lau G, Lo DS, Yao YJ, et al. A fatal case of hepatic failure possibly induced by nitrosofenfluramine: a case report. Med Sci Law 2004;44:252-63
   PubMed Web of Science ®Google Scholar
• Peyrin-Biroulet L, Petitpain N, Kalt P, et al. Probable hepatotoxicity from epigallocatecol gallate used for phytotherapy. Gastroenterol Clin Biol 2004;28:404-6; Article in French
   PubMed Web of Science ®Google Scholar
• Abu el Wafa Y, Benaventa Fernandez A, Talavera Fabuel A, et al. Acute hepatitis induced by Camellia sinensis (green tea). An Med Interna 2005;22:298
   PubMedGoogle Scholar
• Gloro R, Hourmand-Ollivier I, Mosquet B, et al. Fulminant hepatitis during self-medication with hydroalcoholic extract of green tea. Eur J Gastroenterol Hepatol 2005;17:1135-7
   PubMed Web of Science ®Google Scholar
• Mathieu N, Bouallegue L, Mognol P, et al. Hepatic toxicity probably due to X-elles in phytotherapy. Gastroenterol Clin Biol 2005;29:1188-9
   PubMedGoogle Scholar
• Porcel JM, Beilsa S, Madronero AB. Hepatotoxicity associated with green tea extracts (electronic letters). Available from: www.annals.org/cgi/eletters/142/6/477#1669 [Last accessed 30 July 2014]
   Google Scholar
• Stevens T, Qadri A, Zein NN. Two patients with acute liver injury associated with use of the herbal weight-loss supplement hydroxycut. Ann Intern Med 2005;14:477-8
   Google Scholar
• Jimenez-Saenz M, Martinez-Sanchez M del C. Acute hepatitis associated with the use of green tea infusions. J Hepatol 2006;44:616-7
   PubMed Web of Science ®Google Scholar
• Javaid A, Bonkovsky HL. Hepatotoxicity due to extracts of Chinese green tea (Camellia sinensis): a growing concern. J Hepatol 2006;45:334-5
   PubMed Web of Science ®Google Scholar
• Bonkovsky HL. Hepatotoxicity associated with supplements containing Chinese green tea (Camellia sinensis). Ann Intern Med 2006;144:68-71.Erratum in: Ann Intern Med 2006;144:380
   PubMedGoogle Scholar
• Martinez-Sierra C, Rendon Unceta P, Martin Herrera L. Acute hepatitis after green tea ingestion. Med Clin (Barc) 2006;127:119
   PubMed Web of Science ®Google Scholar
• Molinari M, Watt KD, Kruszyna T, et al. Acute liver failure induced by green tea extracts: case reports and review of the literature. Liver Transpl 2006;12:1892-5
   PubMed Web of Science ®Google Scholar
• Federico A, Tiso A, Loguercio C. A case of hepatotoxicity caused by green tea. Free Rad Biol Med 2007;43:474
   PubMed Web of Science ®Google Scholar
• Björnsson E, Olsson R. Serious adverse liver reactions associated with herbal weight loss supplements. J Hepatol 2007;47:295-7
   PubMed Web of Science ®Google Scholar
• García-Cortés M, Borraz Y, Lucena MI, et al. Liver injury induced by “natural remedies”: an analysis of cases submitted to the Spanish Liver Toxicity Registry. Rev Esp Enferm Dig 2008;100:688-95
   PubMed Web of Science ®Google Scholar
• Shim M, Saab S. Severe hepatotoxicity due to Hydroxycut: a case report. Dig Dis Sci 2009;54:406-8
   PubMed Web of Science ®Google Scholar
• Mazzanti G, Menniti-Ippolito F, Moro PA, et al. Hepatotoxicity from green tea: a review of the literature and two unpublished cases. Eur J Clin Pharmacol 2009;65:331-41
   PubMed Web of Science ®Google Scholar
• Sharma T, Wong L, Tsai N, et al. Hydroxycut® (herbal weight loss supplement) induced hepatotoxicity: a case report and review of the literature. Hawaii Med J 2010;69:188-90
   PubMedGoogle Scholar
• Chen GC, Ramanathan VS, Law D, et al. Acute liver injury induced by weight-loss herbal supplements. World J Hepatol 2010;2:410-5
   PubMedGoogle Scholar
• Rohde J, Jacobsen C, Kromann-Andersen H. Toxic hepatitis triggered by green tea. Ugeskr Laeger 2011;173:205-6; Abstract in English, article in Danish
   PubMedGoogle Scholar
• Navarro VJ, Bonkovsky HL, Hwang SI, et al. Catechins in dietary supplements and hepatotoxicity. Dig Dis Sci 2013;58:2682-90
   PubMed Web of Science ®Google Scholar
• Patel SS, Beer S, Kearney DL, et al. Green tea extract: a potential cause of acute liver failure. World J Gastroenterol 2013;19:5174-7
   PubMed Web of Science ®Google Scholar
• Teschke R, Schwarzenboeck A, Eickhoff A, et al. Clinical and causality assessment in herbal hepatotoxicity. Expert Opin Drug Saf 2013;12:339-66
   PubMed Web of Science ®Google Scholar
• Teschke R, Frenzel C, Glass X, et al. Herbal hepatotoxicity: a critical review. Br J Clin Pharmacol 2013;75:630-6
   PubMed Web of Science ®Google Scholar
• Health Canada: Black cohosh products and liver toxicity: update. Canadian Adverse Reaction Newsletter. 2010.20:1-3. Available from: www.hc-sc.gc.ca/dhp-mps/medeff/bulletin/carn-bcei_v20n1-eng.php#a1t1; Last accessed 30 July 2014
   Google Scholar
• Teschke R, Zhang L, Long H, et al. Traditional Chinese Medicine and *herbal hepatotoxicity: a tabular compilation of reported cases. Ann Hepatol 2014; In press
   PubMed Web of Science ®Google Scholar
• Teschke R, Wolff A, Frenzel C, et al. Review article: herbal hepatotoxicity - an update on traditional Chinese medicine preparations. Aliment Pharmacol Ther 2014;40:32-50
   PubMed Web of Science ®Google Scholar
• Teschke R. Traditional Chinese Medicine induced liver injury. J Clin Translat Hepatol 2014;2:80-94
   PubMedGoogle Scholar
• ITIS Standard Report Page Camellia sinensis. Available from: www.itis.gov/access.html; Last accessed 30 July 2014
   Google Scholar
• Teschke R, Qiu SX, Xuan TD, et al. Kava and kava hepatotoxicity: requirements for novel experimental, ethnobotanical, and clinical studies based on a review of the evidence. Phytother Res 2011;25:1262-74
   Web of Science ®Google Scholar
• Teschke R, Lebot V. Proposal for a Kava Quality Standardization Code. Food Chem Toxicol 2011;49:2503-16
   PubMed Web of Science ®Google Scholar
• Teschke R, Wolff A, Frenzel C, et al. Herbal hepatotoxicity: a tabular compilation of reported cases. Liver Int 2012;32:1543-56
   PubMed Web of Science ®Google Scholar
• Shaw D. Toxicological risks of Chinese herbs. Planta Med 2010;76:2012-18
   PubMed Web of Science ®Google Scholar
• Ernst E. Adulteration of Chinese herbal medicines with synthetic drugs: a systematic review. J Intern Med 2002;252:107-13
   PubMed Web of Science ®Google Scholar
• De Smet PA. Herbal medicine in Europe – relaxing regulatory standards. N Engl J Med 2005;352:1176-8
   PubMed Web of Science ®Google Scholar
• Posadzki P, Watson L, Ernst E. Contamination and adulteration of herbal medicinal products (HMPs): an overview of systematic reviews. Eur J Clin Pharmacol 2013;69:295-307
   PubMed Web of Science ®Google Scholar
• National Institutes of Health (NIH) and LiverTox: drug record. Chi R Yun (Breynia officinalis). Last updated 25 October 2013. Available from: http://livertox.nih.gov/ChiRYun.htm; Accessed 30 July 2014
   Google Scholar
• Zhang L, Yan J, Liu X, et al. Pharmacovigilance practice and risk control of Traditional Chinese Medicine drugs in China: current status and future perspective. J Ethnopharmacol 2012;140:519-25
   PubMed Web of Science ®Google Scholar
• Feng WY. Metabolism of green tea catechins: an overview. Curr Drug Metab 2006;7:755-809
   PubMed Web of Science ®Google Scholar
• Williamson G, Dionisi F, Renouf M. Flavanols from green tea and phenolic acids from coffee: critical quantitative evaluation of the pharmacokinetic data in humans after consumption of single doses of beverages. Mol Nutr Food Res 2011;55:864-73
   PubMed Web of Science ®Google Scholar
• Zhou S, Lim LY, Chowbay B. Herbal modulation of P-glycoprotein. Drug Metab Rev 2004;36:57-104
   PubMed Web of Science ®Google Scholar
• Lee MJ, Maliakal P, Chen L, et al. Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol Biomarkers Prev 2002;1:1025-32
   Google Scholar
• Jodoin J, Demeule M, Beliveau R. Inhibition of the multidrug resistance P-glycoprotein activity by green tea polyphenols. Biochim Biophys Acta 2002;1542:149-59
   PubMed Web of Science ®Google Scholar
• Chen L, Lee MJ, Li H, et al. Absorption, distribution, and elimination of tea polyphenols in rats. Drug Metab Dispos 1997;25:1045-50
   PubMed Web of Science ®Google Scholar
• Misaka S, Kawabe K, Onoue S, et al. Effects of green tea catechins on cytochrome P450 2B6, 2C8, 2C19, 2D6 and 3A activities in human liver and intestinal microsomes. Drug Metab Pharmacokinetic 2013;28:244-9
   PubMed Web of Science ®Google Scholar
• Chow HHS, Hakim IA, Vining DR, et al. Effects of repeated green tea catechins administration on human cytochrome P450 activity. Cancer Epidemiol Biomarkers Prev 2006;15:2473-6
   PubMed Web of Science ®Google Scholar
• Muto S, Fujita K, Yamazaki Y, et al. Inhibition by green tea catechins of metabolic activation of procarcinogens by human cytochrome P450. Mutat Res 2001;479:197-206
   PubMed Web of Science ®Google Scholar
• Danan G, Bénichou C. Causality assessment of adverse reactions to drugs – I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993;46:1323-30
   PubMed Web of Science ®Google Scholar
• Teschke R, Wolff A, Frenzel C, et al. Drug and herb induced liver injury: council for International Organizations of Medical Sciences scale for causality assessment. World J Hepatol 2014;6:17-32
   PubMedGoogle Scholar
• Teschke R, Genthner A, Wolff A, et al. Herbal hepatotoxicity: analysis of cases with initially reported positive reexposure tests. Dig Liv Dis 2014;46:264-9
   Web of Science ®Google Scholar
• Nishikawa M, Ariyoshi N, Kotani A, et al. Effects of continuous ingestion of green tea or grape seed extracts on the pharmacokinetics of midazolam. Drug Metab Pharmacokinetic 2004;19:280-9
   PubMedGoogle Scholar
• Guengerich FP. Cytochrome P-450 3A4: regulation and role in drug metabolism. Annual Rev Pharmacol Toxicol 1999;39:1-17
   PubMed Web of Science ®Google Scholar
• Donovan JL, Chavin KD, Devane CL, et al. Green tea (Camellia sinensis) extract does not alter cytochrome p450 3A4 or 2D6 activity in healthy volunteers. Drug Metab Disp 2004;32:906-8
   PubMed Web of Science ®Google Scholar
• Buch AB, van Harken DR, Seidehamel RJ, et al. A study of pharmacokinetic interaction between buspirone and alprazolam at steady state. J Clin Pharmacol 1993;33:1104-9
   PubMed Web of Science ®Google Scholar
• Kharasch ED, Whittington D, Hoffer C. Influence of hepatic and intestinal cytochrome P4503A activity on the acute disposition and effects of oral transmucosal fentanyl citrate. Anesthesiology 2004;101:729-37
   PubMed Web of Science ®Google Scholar
• Flockhart DA, Rae JM. Cytochrome P450 3A pharmacogenetics: the road that needs traveled. The Pharmacogenomics J 2003;3:3-5
   PubMed Web of Science ®Google Scholar
• Westlind A, Löfberg L, Tindberg N, et al. Interindividual differences in hepatic expression of CYP3A4: relationship to genetic polymorphism in the 5′-upstream regulatory region. Biochem Biophys Res Commun 1999;259:201-5
   PubMed Web of Science ®Google Scholar
• Gallo E, Maggini V, Berardi M, et al. Is green tea a potential trigger for autoimmune hepatitis? Phytomedicine 2013;20:1186-9
   PubMed Web of Science ®Google Scholar
• Kennedy DA, Seely D. Clinically based evidence of drug–herb interactions: a systematic review. Expert Opin Drug Saf 2010;9:79-124
   PubMed Web of Science ®Google Scholar
• Akbar Abolfathi A, Mohajeri D, Rezaie A, Nazeri M. Protective effects of green tea extract against hepatic tissue injury in streptozotocin-induced diabetic rats. Evidence-based Complement Altern Med 2012;2012:740671
   PubMedGoogle Scholar
• El-Beshbishy HA. Hepatoprotective effect of green tea (Camellia sinensis) extract against tamoxifen-induced liver injury in rats. J Biochem Mol Biol 2005;38:563-70
   PubMedGoogle Scholar
• Dey P, Saha MR, Sen A. Hepatotoxicity and the present herbal hepatoprotective scenario. Int J Green Pharm 2013;7:265-73
   Google Scholar
• Masterjohn C, Bruno RS. Therapeutic potential of green tea in nonalcoholic fatty liver disease. Nutr Rev 2012;70:41-56
   PubMed Web of Science ®Google Scholar